Jardine, which is buying I-MED over from UK private equity firm Permira, will fund the deal with its own cash and that its underlying EPS and dividend guidance for FY2026 remainsJardine Matheson ...
Source LinkJardine, which is buying I-MED over from UK private equity firm Permira, will fund the deal with its own cash and that its underlying EPS and dividend guidance for FY2026 remainsJardine Matheson ...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.